Literature DB >> 9116999

IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis.

R A Taha1, T C Kotsimbos, Y L Song, D Menzies, Q Hamid.   

Abstract

Cytokine-mediated immune responses to Mycobacterium tuberculosis infection are important determinants of M. tuberculosis disease development and pathology. However, the distinction between changes in cytokine profile attributable to M. tuberculosis infection and those associated with active pulmonary tuberculosis is unclear. We have compared T cells and their subsets, macrophages, and cytokine messenger RNA (mRNA) profile in the bronchoalveolar lavage (BAL) of patients with active pulmonary tuberculosis with inactive tuberculosis subjects. Ten patients with microbiologically confirmed active pulmonary tuberculosis and 25 subjects with inactive tuberculosis were recruited. Bronchoscopy with BAL was undertaken in all cases and BAL cytospins were examined using the techniques of immunocytochemistry and in situ hybridization. There was a significant increase in the percentage of BAL cells that were CD8+ T cells in active tuberculosis compared with inactive tuberculosis (mean +/- SEM: 7.2 +/- 0.9 versus 2.1 +/- 0.4, p < 0.001), but not CD3+ or CD4+ T cells nor macrophages. There were significant increases in the percentage of BAL cells expressing mRNA for interferon-gamma (IFN-gamma) and interleukin-12 (IL-12) in active versus inactive pulmonary tuberculosis subjects (8.0 +/- 0.6 versus 3.7 +/- 0.4 and 28.4 +/- 2.3 versus 10.2 +/- 1.0, p < 0.001, respectively). There were no significant differences between the active and inactive groups in the number of cells expressing mRNA for IL-2, tumor necrosis factor-alpha (TNF-alpha), IL-4, and IL-5. In conclusion, active pulmonary tuberculosis is associated with increased numbers of CD8+ cells and marked increases in the expression of IL-12 and IFN-gamma mRNA in the BAL, both of which may be useful markers of disease activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9116999     DOI: 10.1164/ajrccm.155.3.9116999

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  27 in total

1.  Cytokine polarization in miliary and pleural tuberculosis.

Authors:  Surendra K Sharma; Dipender K Mitra; Arumugam Balamurugan; Ravindra M Pandey; Narinder K Mehra
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

2.  T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis.

Authors:  G Mazzarella; A Bianco; F Perna; D D'Auria; E Grella; E Moscariello; A Sanduzzi
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

3.  Extra-pulmonary tuberculosis: a biomarker analysis.

Authors:  J Fortún; P Martín-Dávila; E Gómez-Mampaso; A Vallejo; C Cuartero; A González-García; J Rubí; E Pallarés; S Moreno
Journal:  Infection       Date:  2014-03-21       Impact factor: 3.553

4.  Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease.

Authors:  F Abebe; T Mustafa; A H Nerland; G A Bjune
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

5.  Low in vitro production of interferon-gamma and tumor necrosis factor-alpha in HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria.

Authors:  U Greinert; M Schlaak; S Rüsch-Gerdes; H D Flad; M Ernst
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

6.  Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis.

Authors:  S Bhattacharyya; R Singla; A B Dey; H K Prasad
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.

Authors:  M Glória Bonecini-Almeida; John L Ho; Neio Boéchat; Richard C Huard; Sadhana Chitale; Howard Doo; Jiayuan Geng; Lorena Rego; Luiz Claudio Oliveira Lazzarini; Afrânio L Kritski; Warren D Johnson; Timothy A McCaffrey; José R Lapa e Silva
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis.

Authors:  Craig L Fuller; JoAnne L Flynn; Todd A Reinhart
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis.

Authors:  Maria Teresa Herrera; Martha Torres; Denarra Nevels; Carlos Núñez Perez-Redondo; Jerrold J Ellner; Eduardo Sada; Stephan K Schwander
Journal:  Tuberculosis (Edinb)       Date:  2008-10-09       Impact factor: 3.131

10.  Ca-125: a useful marker to distinguish pulmonary tuberculosis from other pulmonary infections.

Authors:  J Fortún; P Martín-Dávila; R Méndez; A Martínez; F Norman; J Rubi; E Pallares; E Gómez-Mampaso; S Moreno
Journal:  Open Respir Med J       Date:  2009-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.